Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 3

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 3
---
ailer, a physician with decades of patient experience.

#### Making a Difference in Our Communities
In 2024 we launched a new multi-year philanthropic and community engagement initiative focused on partnering with nonprofit organizations with expertise in three essential areas: improving youth mental health, improving veteran mental health, with an emphasis on housing stability, and reducing barriers to health equity. As part of this engagement initiative, The Cigna Group Foundation will allocate more than $27 million in grants to nonprofit organizations over the next three years.

#### Annual Meeting of Shareholders
On behalf of The Cigna Group Board of Directors, we invite you to attend our 2025 Annual Meeting of Shareholders, to be held April 23, 2025. The attached Notice of 2025 Annual Meeting of Shareholders and Proxy Statement contains important information about the business to be conducted.

We look forward to continuing to serve our customers, patients, and clients and delivering attractive value creation and sustained growth in the years ahead. On behalf of our employees around the world and the entire Board of Directors, we thank you for your support and investment in The Cigna Group.

Sincerely,

| /s/ David M. Cordani                       |     | /s/ Eric C. Wiseman       |
| David M. Cordani                           |     | Eric C. Wiseman           |
| Chairman and Chief Executive Officer (CEO) |     | Lead Independent Director |

* Consolidated adjusted income from operations and adjusted income from operations per share are non-GAAP measures. See Annex A to the Proxy Statement for a reconciliation of GAAP to non-GAAP measures, as well as a reconciliation of segment metrics to their comparable consolidated metrics.

#### Notice of 2025 Annual
Meeting of Shareholders

| Meeting Details |     |                                                                                                |     |                      Date 
 Wednesday, April 23, 2025 |     | 1                                                                                                                                      |     | Items of Business                                                                                                                           
 Election of eleven director nominees named in this Proxy Statement for one-year terms to expire at the next annual meeting of shareholders. |
|:----------------|:----|:-----------------------------------------------------------------------------------------------|:----|--------------------------:|:----|:---------------------------------------------------------------------------------------------------------------------------------------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------|
| 2               |     | Advisory approval of executive compensation.                                                   |     |                           |     |                                                                                                                                        |     |                                                                                                                                             |
|                 |     | Time                                                                                           
 10:00 a.m. Eastern Time                                                                        |     |                         3 |     | Ratification of the appointment